Drug intelligence / Profile preview

placental-derived autologous mesenchymal stem cells

Development stage
Unknown
Lead developer
PLA Army Specialty Medical Center
Modality
Stem Cell Therapies → Cell Therapies
Administration
Intravenous
01

Overview

Placental-derived autologous mesenchymal stem cells (MSCs) are an experimental cell therapy being investigated for the treatment of bronchopulmonary dysplasia (BPD) in premature infants. The therapy involves isolating MSCs from the infant's own placenta, expanding them in vitro, and subsequently re-administering them to the same infant via intravenous infusion. These cells are hypothesized to exert therapeutic effects by migrating to injured lung tissue and secreting a variety of paracrine factors, including anti-inflammatory cytokines and growth factors, which promote tissue repair, reduce inflammation, and support angiogenesis in the developing neonatal lung.

Other names
autologous placental mesenchymal stem cellsplacenta-derived autologous MSCs

Beyond the preview

Go deeper on placental-derived autologous mesenchymal stem cells.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on placental-derived autologous mesenchymal stem cells.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call